Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|---|
PTCT | PTC THERAPEUTICS INC | $3.65B | 79,257,019 | 82.51% | 17.49% | Net Selling | Net Selling | ||
AUPH | AURINIA PHARMACEUTICALS INC | $1.11B | 135,104,302 | 37.02% | 11.36% | Net Buying | Net Buying | ||
INCY | INCYTE CORP | $12.25B | 193,569,934 | 70.95% | 29.05% | Net Selling | Net Selling | ||
EXEL | EXELIXIS INC | $12.38B | 272,708,280 | 85.55% | 5.33% | Net Selling | Net Selling | ||
CPRX | CATALYST PHARMACEUTICALS INC | $2.97B | 121,975,152 | 73.80% | 16.05% | Net Buying | Net Selling | ||
HALO | HALOZYME THERAPEUTICS INC | $6.41B | 123,221,000 | 76.77% | 23.23% | Net Selling | Net Selling | ||
RIGL | RIGEL PHARMACEUTICALS INC | $354.50M | 17,872,432 | 32.85% | 67.15% | Net Selling | |||
BCRX | BIOCRYST PHARMACEUTICALS INC | $2.14B | 209,250,274 | 72.88% | 17.72% | Net Selling | Net Selling | ||
PBYI | PUMA BIOTECHNOLOGY INC | $168.27M | 49,638,093 | 52.31% | 43.75% | Net Selling | |||
BMRN | BIOMARIN PHARMACEUTICAL INC | $11.37B | 191,775,665 | 86.62% | 1.71% | Net Selling | Net Selling | ||
NAGE | NIAGEN BIOSCIENCE INC | $862.53M | 78,769,662 | 13.51% | 86.49% | Net Buying | Net Buying | ||
CRMD | CORMEDIX INC | $832.89M | 67,824,659 | 29.65% | 9.81% | Net Selling | Net Buying | ||
ZVRA | ZEVRA THERAPEUTICS INC | $473.53M | 54,679,641 | 63.82% | 22.65% | Net Selling | Net Buying | ||
CSBR | CHAMPIONS ONCOLOGY INC | $87.80M | 13,826,904 | 1.15% | 98.85% | Net Buying | |||
PLX | PROTALIX BIOTHERAPEUTICS INC | $132.94M | 79,607,115 | 4.78% | 95.22% | ||||
INVA | INNOVIVA INC | $1.17B | 62,775,173 | 54.59% | 45.41% | Net Selling | Net Selling | ||
THTX | THERATECHNOLOGIES INC | $120.01M | 45,980,019 | 27.61% | 0.00% | ||||
IMCR | IMMUNOCORE HOLDINGS PLC | $1.53B | 50,233,609 | 84.45% | 4.33% | Net Buying | Net Buying | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | $37.20B | 130,388,393 | 81.76% | 18.24% | Net Selling | Net Selling | ||
KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $1.92B | 72,970,967 | 38.24% | 9.62% | Net Selling | Net Selling | ||
ONC | BEIGENE LTD | $24.68B | 1,403,311,086 | 2.11% | 33.07% | Net Selling | Net Buying | ||
GMAB | GENMAB A | $13.16B | 66,197,244 | 62.06% | 0.00% | ||||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.01B | 57,424,319 | 68.47% | 31.53% | Net Selling | Net Selling | ||
AKBA | AKEBIA THERAPEUTICS INC | $685.48M | 262,635,836 | 31.73% | 7.65% | Net Selling | Net Selling | ||
XLO | XILIO THERAPEUTICS INC | $44.48M | 51,782,273 | 39.33% | 60.67% | Net Buying | |||
NVO | NOVO NORDISK A S | $287.41B | 4,465,000,000 | 6.94% | 0.00% | ||||
MNKD | MANNKIND CORP | $1.33B | 303,932,852 | 33.70% | 66.30% | Net Selling | Net Selling | ||
ZLAB | ZAI LAB LTD | $3.36B | 1,084,743,860 | 5.09% | 1.75% | Net Selling | Net Selling | ||
BDTX | BLACK DIAMOND THERAPEUTICS INC | $110.88M | 56,862,635 | 65.01% | 34.99% | Net Selling | Net Selling | ||
VCYT | VERACYTE INC | $2.29B | 78,314,611 | 65.25% | 34.75% | Net Selling | Net Selling | ||
RPRX | ROYALTY PHARMA PLC | $19.13B | 562,240,269 | 50.93% | 17.76% | Net Buying | Net Buying | ||
STOK | STOKE THERAPEUTICS INC | $532.87M | 54,596,924 | 46.03% | 53.97% | Net Selling | Net Selling | ||
WHWK | WHITEHAWK THERAPEUTICS INC | $81.03M | 47,109,293 | 32.93% | 67.07% | Net Buying | Net Buying | ||
VRTX | VERTEX PHARMACEUTICALS INC | $112.64B | 256,797,187 | 87.24% | 1.51% | Net Selling | Net Selling | ||
XOMA | XOMA ROYALTY CORP | $322.99M | 11,966,889 | 11.81% | 88.19% | Net Selling | Net Buying | ||
HRTX | HERON THERAPEUTICS INC | $300.55M | 152,563,634 | 48.10% | 51.90% | ||||
KROS | KEROS THERAPEUTICS INC | $571.46M | 40,615,414 | 67.26% | 32.74% | Net Buying | Net Buying | ||
TECH | BIO-TECHNE CORP | $7.71B | 156,767,295 | 97.61% | 2.39% | Net Buying | Net Buying | ||
ZYME | ZYMEWORKS INC | $815.99M | 69,683,492 | 47.69% | 52.31% | Net Buying | Net Buying | ||
TVTX | TRAVERE THERAPEUTICS INC | $1.49B | 88,804,818 | 61.35% | 38.65% | Net Selling | Net Selling | ||
FENC | FENNEC PHARMACEUTICALS INC | $188.91M | 27,618,743 | 3.62% | 96.38% | Net Selling | Net Selling | ||
TARS | TARSUS PHARMACEUTICALS INC | $1.84B | 42,014,237 | 68.91% | 31.09% | Net Selling | Net Selling | ||
VRNA | VERONA PHARMA PLC | $6.07B | 681,056,022 | 8.01% | 52.65% | Net Selling | Net Selling | ||
XERS | XERIS BIOPHARMA HOLDINGS INC | $781.56M | 160,155,000 | 46.59% | 15.24% | Net Selling | Net Selling | ||
ARGX | ARGENX SE | $34.37B | 60,760,957 | 51.94% | 0.00% | ||||
VXRT | VAXART INC | $115.25M | 228,222,953 | 11.55% | 54.59% | Net Selling | Net Selling | ||
ARWR | ARROWHEAD PHARMACEUTICALS INC | $2.17B | 138,100,435 | 69.34% | 9.93% | Net Selling | Net Selling | ||
MDXG | MIMEDX GROUP INC | $1.04B | 147,702,140 | 44.99% | 55.01% | Net Buying | Net Buying | ||
PVLA | PALVELLA THERAPEUTICS INC | $243.78M | 11,055,665 | 23.26% | 56.13% | Net Buying | Net Buying | ||
UTHR | UNITED THERAPEUTICS CORP | $13.77B | 45,106,623 | 86.61% | 13.39% | Net Selling | Net Buying | ||
TGTX | TG THERAPEUTICS INC | $5.45B | 158,755,036 | 54.82% | 45.18% | Net Selling | |||
MIRM | MIRUM PHARMACEUTICALS INC | $2.23B | 49,534,709 | 46.35% | 53.65% | Net Selling | Net Selling | ||
FTRE | FORTREA HOLDINGS INC | $399.60M | 90,000,000 | 78.54% | 0.35% | Net Selling | Net Selling | ||
IMAB | I-MAB | $73.48M | 187,679,483 | 1.57% | 0.00% | ||||
TBPH | THERAVANCE BIOPHARMA INC | $460.01M | 50,001,332 | 42.45% | 57.55% | Net Buying | Net Selling | ||
FHTX | FOGHORN THERAPEUTICS INC | $246.93M | 55,741,373 | 29.80% | 14.32% | Net Selling | |||
ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $1.37B | 151,916,722 | 61.32% | 38.68% | Net Selling | Net Selling | ||
TLX | TELIX PHARMACEUTICALS LTD | $5.58B | 334,724,485 | 0.01% | 0.00% | ||||
LGND | LIGAND PHARMACEUTICALS INC | $2.02B | 19,294,168 | 16.59% | 83.41% | Net Selling | Net Buying | ||
ATRA | ATARA BIOTHERAPEUTICS INC | $40.78M | 5,961,391 | 15.98% | 84.02% | Net Buying | Net Buying | ||
NVAX | NOVAVAX INC | $1.09B | 161,970,338 | 54.79% | 17.12% | Net Selling | Net Selling | ||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.68B | 119,201,724 | 74.45% | 25.55% | Net Selling | Net Selling | ||
SEER | SEER INC | $121.86M | 58,868,846 | 38.00% | 52.75% | Net Selling | Net Selling | ||
BPMC | BLUEPRINT MEDICINES CORP | $6.57B | 64,582,163 | 81.43% | 18.57% | Net Selling | Net Selling | ||
FOLD | AMICUS THERAPEUTICS INC | $1.98B | 307,930,984 | 61.29% | 38.71% | Net Selling | Net Selling | ||
ACAD | ACADIA PHARMACEUTICALS INC | $3.73B | 167,361,851 | 63.00% | 37.00% | Net Selling | Net Selling | ||
CORT | CORCEPT THERAPEUTICS INC | $7.96B | 106,044,696 | 28.59% | 71.41% | Net Buying | Net Selling | ||
MDGL | MADRIGAL PHARMACEUTICALS INC | $6.46B | 22,203,282 | 21.91% | 78.09% | Net Selling | Net Buying | ||
RGNX | REGENXBIO INC | $445.93M | 50,160,352 | 75.34% | 24.66% | Net Selling | Net Buying | ||
AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $1.97B | 348,266,581 | 0.06% | 0.00% | ||||
GYRE | GYRE THERAPEUTICS INC | $1.06B | 93,757,602 | 1.58% | 98.42% | Net Buying | Net Buying | ||
SEPN | SEPTERNA INC | $437.31M | 44,442,496 | 61.81% | 38.19% | Net Buying | Net Buying | ||
IPSC | CENTURY THERAPEUTICS INC | $48.19M | 86,045,033 | 25.86% | 45.63% | Net Selling | Net Selling | ||
KRYS | KRYSTAL BIOTECH INC | $3.77B | 28,898,680 | 77.47% | 22.53% | Net Selling | Net Selling | ||
ACOG | ALPHA COGNITION INC | $138.57M | 16,019,787 | 27.77% | 5.15% | Net Buying | |||
AEON | AEON BIOPHARMA INC | $5.65M | 11,305,367 | 5.32% | 94.68% | ||||
VALN | VALNEVA SE | $509.12M | 162,397,202 | 0.39% | 0.00% | ||||
CADL | CANDEL THERAPEUTICS INC | $268.05M | 50,102,679 | 36.87% | 31.46% | Net Selling | Net Selling | ||
ACIU | AC IMMUNE SA | $171.70M | 100,410,377 | 4.58% | 0.00% | ||||
GLUE | MONTE ROSA THERAPEUTICS INC | $244.81M | 61,509,821 | 27.81% | 72.19% | Net Selling | Net Buying | ||
CANF | CAN-FITE BIOPHARMA LTD | $9.40M | 2,983,181,793 | 0.00% | 0.00% | ||||
CTMX | CYTOMX THERAPEUTICS INC | $163.66M | 80,621,293 | 27.35% | 26.79% | Net Selling | Net Selling | ||
LEGN | LEGEND BIOTECH CORP | $5.11B | 368,058,079 | 18.24% | 0.00% | ||||
IKT | INHIBIKASE THERAPEUTICS INC | $149.43M | 74,341,540 | 52.69% | 24.73% | Net Buying | |||
MESO | MESOBLAST LTD | $1.35B | 1,152,444,429 | 0.27% | 0.00% | ||||
RARE | ULTRAGENYX PHARMACEUTICAL INC | $3.37B | 94,542,035 | 81.69% | 16.91% | Net Selling | Net Selling | ||
TLSA | TIZIANA LIFE SCIENCES LTD | $151.59M | 111,462,617 | 2.66% | 0.00% | ||||
ARVN | ARVINAS INC | $473.71M | 72,991,390 | 67.80% | 30.88% | Net Selling | Net Selling | ||
CNTA | CENTESSA PHARMACEUTICALS PLC | $1.67B | 133,618,774 | 80.19% | 9.91% | Net Selling | Net Selling | ||
TSHA | TAYSHA GENE THERAPIES INC | $579.59M | 214,661,715 | 66.93% | 14.58% | Net Buying | Net Selling | ||
REGN | REGENERON PHARMACEUTICALS INC | $64.17B | 107,965,497 | 68.22% | 31.78% | Net Selling | |||
TCRX | TSCAN THERAPEUTICS INC | $70.17M | 56,590,627 | 53.32% | 25.38% | Net Buying | |||
SLS | SELLAS LIFE SCIENCES GROUP INC | $162.64M | 99,777,487 | 13.93% | 8.65% | Net Selling | |||
KLRS | KALARIS THERAPEUTICS INC | $65.08M | 18,702,418 | 0.56% | 99.44% | Net Selling | Net Selling | ||
ADMA | ADMA BIOLOGICS INC | $4.70B | 238,734,246 | 77.55% | 22.45% | Net Selling | Net Selling | ||
HLVX | HILLEVAX INC | $98.78M | 50,141,064 | 63.46% | 36.54% | Net Selling | |||
PHIO | PHIO PHARMACEUTICALS CORP | $8.79M | 4,778,154 | 0.10% | 99.90% | Net Buying | |||
NRSN | NEUROSENSE THERAPEUTICS LTD | $30.66M | 23,228,941 | 0.84% | 0.00% | ||||
IMNM | IMMUNOME INC | $701.32M | 87,012,328 | 72.20% | 7.69% | Net Buying | Net Buying | ||
ASMB | ASSEMBLY BIOSCIENCES INC | $102.50M | 7,637,553 | 23.96% | 76.04% | Net Buying | Net Selling |